Substrates for peptidase C25.002: gingipain K
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| adrenocorticotrophin (11-24) | P01189 | 148-161 | Lys-Pro-Val-Gly-Lys+Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | N | Pro | Val | Gly | Lys | Lys | Arg | Arg | Pro | Pike et al., 1994 | |||
| adrenocorticotrophin (11-24) | P01189 | 148-161 | Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys+Val-Tyr-Pro | N | Arg | Pro | Val | Lys | Val | Tyr | Pro | - | Pike et al., 1994 | |||
| arginine-specific cysteine proteinase RgpA | B2RM93 | 1-1703 | peptide-Lys686+Thr-peptide | P | CS | Pro | Ser | Thr | Lys | Thr | Asn | Ala | Thr | Veith et al., 2004 | ||
| arginine-specific cysteine proteinase RgpA | B2RM93 | 1-1703 | peptide-Lys1402+Lys-peptide | P | CS | Pro | Ser | Ala | Lys | Lys | Thr | Glu | Gly | Veith et al., 2004 | ||
| arginine-specific cysteine proteinase RgpA | B2RM93 | 1-1703 | peptide-Lys1079+Gly-peptide | P | CS | Ile | Thr | Ala | Lys | Gly | Val | Arg | Ser | Veith et al., 2004 | ||
| arginine-specific cysteine proteinase RgpA | B2RM93 | 1-1703 | peptide-Lys1255+Gly-peptide | P | CS | Gly | Ile | Asn | Lys | Gly | Gly | Ala | Arg | Veith et al., 2004 | ||
| beta-endorphin | P01189 | 237-267 | peptide-Lys18+Asn-peptide | N | Thr | Leu | Phe | Lys | Asn | Ala | Ile | Ile | Pike et al., 1994 | 16288 | ||
| beta-endorphin | P01189 | 237-267 | peptide-Lys23+Asn-peptide | N | Ala | Ile | Ile | Lys | Asn | Ala | Tyr | Lys | Pike et al., 1994 | 16289 | ||
| beta-endorphin | P01189 | 237-267 | peptide-Lys27+Lys-peptide | N | Asn | Ala | Tyr | Lys | Lys | Gly | Glu | - | Pike et al., 1994 | 16290 | ||
| beta-endorphin | P01189 | 237-267 | peptide-Lys8+Ser-peptide | N | Thr | Ser | Glu | Lys | Ser | Gln | Thr | Pro | Pike et al., 1994 | 16291 | ||
| C5a anaphylatoxin chemotactic receptor | P21730 | 9-29 | Peptide-Lys17+Asp-Peptide | N | NT | Tyr | Asp | Asp | Lys | Asp | Thr | Leu | Asp | Jagels et al., 1996 | ||
| C5a anaphylatoxin chemotactic receptor | P21730 | 9-29 | Peptide-Lys28+Thr | N | NT | Pro | Val | Asp | Lys | Thr | - | - | - | Jagels et al., 1996 | ||
| consensus lysyl bond | peptide-Lys+peptide | N | - | - | NPe | Lys | CPe | - | - | - | Pike et al., 2004 | |||||
| D-Val-Leu-Lys-NHPhNO2 | D-Val-Leu-Lys+NHPhNO2 | S | - | DVa | Leu | Lys | NAN | - | - | - | Pike et al., 1994 | |||||
| D-Val-Phe-Lys-NHPhNO2 | D-Val-Phe-Lys+NHPhNO2 | S | - | DVa | Phe | Lys | NAN | - | - | - | Pike et al., 1994 | |||||
| hagA protein | P59915 | 26-2164 | peptide-Lys1212+Pro-peptide | P | Asn | Gly | Ala | Lys | Pro | Gln | Ser | Val | Imamura et al., 2004 | 16293 | ||
| hagA protein | P59915 | 26-2164 | peptide-Arg684+Ala-peptide | P | Asn | Gly | Lys | Arg | Ala | Asp | Phe | Thr | Imamura et al., 2004 | 16292 | ||
| interleukin-6 | P05231 | 30-212 | peptide-Lys199+Glu-peptide | P | Arg | Ser | Phe | Lys | Glu | Phe | Leu | Gln | Banbula et al., 1999 | 18861 | ||
| interleukin-8 | P10145 | 23-99 | peptide-Lys30+Glu-peptide | P | Arg | Ser | Ala | Lys | Glu | Leu | Arg | Cys | Dias et al., 2007 | 20568 | ||
| interleukin-8 | P10145 | 23-99 | peptide-Lys38+Thr-peptide | P | Gln | Cys | Ile | Lys | Thr | Tyr | Ser | Lys | Dias et al., 2007 | 20571 | ||
| interleukin-8 | P10145 | 23-99 | peptide-Lys42+Pro-peptide | P | Thr | Tyr | Ser | Lys | Pro | Phe | His | Pro | Dias et al., 2007 | 20572 | ||
| lys-gingipain | Q6Q4T4 | 1-1358 | peptide-Lys928+Gly-peptide | P | CS | Gly | Ile | Asn | Lys | Gly | Gly | Ala | Arg | Veith et al., 2004 | ||
| lys-gingipain | Q6Q4T4 | 1-1358 | peptide-Lys1077+Arg-peptide | P | CS | Pro | Ala | Ser | Lys | Arg | Ala | Glu | Val | Veith et al., 2004 | ||
| lys-gingipain | P72194 | 1-1723 | peptide-Lys1422+Arg-peptide | P | CS | Pro | Ser | Gly | Lys | Arg | Gly | Glu | Leu | Veith et al., 2004 | ||
| lys-gingipain | P72194 | 1-1723 | peptide-Lys1099+Gly-peptide | P | CS | Ile | Thr | Ala | Lys | Gly | Val | Arg | Ser | Veith et al., 2004 | ||
| lys-gingipain | P72194 | 1-1723 | peptide-Lys1275+Gly-peptide | P | CS | Gly | Ile | Asn | Lys | Gly | Gly | Ala | Arg | Veith et al., 2004 | ||
| lys-gingipain W83 | Q51817 | 25-1732 | Lys+Ile-peptide | P | NT | - | - | - | Lys | Ile | Lys | Leu | Asp | Huq et al., 2013 | ||
| lys-gingipain W83 | Q51817 | 25-1732 | peptide-Lys60+Gly-peptide | P | NT | Val | Glu | Thr | Lys | Gly | Gly | Thr | Phe | Huq et al., 2013 | ||
| lys-gingipain W83 | Q51817 | 25-1732 | peptide-Lys88+Leu-peptide | P | NT | Ala | Val | Arg | Lys | Leu | Ile | Ala | Val | Huq et al., 2013 | ||
| lys-gingipain W83 | Q51817 | 25-1732 | peptide-Lys119+Leu-peptide | P | NT | Gly | Ser | Glu | Lys | Leu | Met | Pro | His | Huq et al., 2013 | ||
| lys-gingipain W83 | Q51817 | 25-1732 | peptide-Lys129+Ser-peptide | P | NT | Ser | Met | Ser | Lys | Ser | Asp | Asp | Pro | Huq et al., 2013 | ||
| lys-gingipain W83 | Q51817 | 25-1732 | peptide-Lys148+Gly-peptide | P | NT | Tyr | Ala | Arg | Lys | Gly | Phe | Val | Gly | Huq et al., 2013 | ||
| lys-gingipain W83 | Q51817 | 25-1732 | peptide-Lys187+Val-peptide | P | NT | Asn | Gln | Leu | Lys | Val | Arg | Asn | Asn | Huq et al., 2013 | ||
| lys-gingipain W83 | Q51817 | 25-1732 | peptide-Lys223+Gln-peptide | P | NT | Thr | Ala | Tyr | Lys | Gln | Leu | Phe | Asn | Huq et al., 2013 | ||
| Lys-Pro bond | peptide-Lys+Pro-peptide | N | - | - | NPe | Lys | Pro | CPe | - | - | Pike et al., 2004 | |||||
| melittin | P01501 | 44-69 | Gly-Ile-Gly-Ala-Val-Leu-Lys+Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2 | N | Ala | Val | Leu | Lys | Val | Leu | Thr | Thr | Pike et al., 1994 | 16294 | ||
| mellitin | P01501 | 44-69 | Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys+Arg-Lys-Arg-Gln-Gln-NH2 | N | Ser | Trp | Ile | Lys | Arg | Lys | Arg | Gln | Pike et al., 1994 | |||
| neurotensin | P30990 | 151-163 | Glp-Leu-Tyr-Glu-Asn-Lys+Pro-Arg-Arg-Pro-Tyr-Ile-Leu | N | Tyr | Glu | Asn | Lys | Pro | Arg | Arg | Pro | Pike et al., 1994 | 16296 | ||
| synthetic peptide 1 | Glu-Glu-Ile-Ser-Glu-Val-Lys+Met-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-lu-Val-His-His-Gln-Lys-Leu-Val-Phe | N | Ser | Glu | Val | Lys | Met | Asp | Ala | Glu | Pike et al., 1994 | |||||
| synthetic peptide 1 | Glu-Glu-Ile-Ser-Glu-Val-Lys-Met-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-lu-Val-His-His-Gln-Lys+Leu-Val-Phe | N | His | His | Gln | Lys | Leu | Val | Phe | - | Pike et al., 1994 | |||||
| synthetic peptide 2 | Glu-Glu-Ile-Ser-Glu-Val-Asp-Leu-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-lu-Val-His-His-Gln-Lys+Leu-Val-Phe | N | His | His | Gln | Lys | Leu | Val | Phe | - | Pike et al., 1994 | |||||
| Tos-Gly-Pro-Lys-NHPhNO2 | Tos-Gly-Pro-Lys+NHPhNO2 | S | Tos | Gly | Pro | Lys | NAN | - | - | - | Pike et al., 2004 | |||||
| tumor necrosis factor | P01375 | 77-233 | peptide-Lys141+Gly-peptide | P | Val | Leu | Phe | Lys | Gly | Gln | Gly | Cys | Calkins et al., 1998 | 20528 | ||
| tumor necrosis factor | P01375 | 77-233 | peptide-Lys166+Val-peptide | P | Tyr | Gln | Thr | Lys | Val | Asn | Leu | Leu | Calkins et al., 1998 | 20529 | ||
| tumor necrosis factor | P01375 | 77-233 | peptide-Lys174+Ser-peptide | P | Ser | Ala | Ile | Lys | Ser | Pro | Cys | Gln | Calkins et al., 1998 | 20530 | ||
| Z-Lys-NHPhNO2 | Z-Lys+NHPhNO2 | S | - | - | Z | Lys | NAN | - | - | - | Pike et al., 2004 | |||||
| [Met-Lys]-bradykinin | P01042 | 379-389 | Met-Lys+Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | N | - | - | Met | Lys | Arg | Pro | Pro | Gly | Pike et al., 1994 |
